tradingkey.logo

AngioDynamics Inc

ANGO
View Detailed Chart
12.020USD
+0.290+2.47%
Close 11/07, 16:00ETQuotes delayed by 15 min
498.19MMarket Cap
LossP/E TTM

AngioDynamics Inc

12.020
+0.290+2.47%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.47%

5 Days

-0.08%

1 Month

+8.09%

6 Months

+29.53%

Year to Date

+31.22%

1 Year

+66.94%

View Detailed Chart

TradingKey Stock Score of AngioDynamics Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

AngioDynamics Inc's Score

Industry at a Glance

Industry Ranking
16 / 209
Overall Ranking
64 / 4614
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
18.500
Target Price
+53.91%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

AngioDynamics Inc Highlights

StrengthsRisks
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Undervalued
The company’s latest PE is -15.37, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.04M shares, decreasing 10.45% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 1.95M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.36.

AngioDynamics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

AngioDynamics Inc Info

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Ticker SymbolANGO
CompanyAngioDynamics Inc
CEOMr. James C. Clemmer
Websitehttps://www.angiodynamics.com/
KeyAI